Intravenous drug abuse and Type 1 diabetes: financial and healthcare implications

Abstract

IVDA-DM patients have higher rates of diabetes complications, are admitted more frequently and have a high mortality compared with DM and IVDA-controls. The cost of inpatient care of this small group of patients was considerable.